臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"shan y s"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 16-65 / 95 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2022-03-08T03:44:01Z	Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study	Chiang N.-J.; Chen M.-H.; SHIH-HUNG YANG; Hsu C.; Yen C.-J.; Tsou H.-H.; Su Y.-Y.; Chen J.-S.; Shan Y.-S.; Chen L.-T.
臺大學術典藏	2022-02-14T05:27:14Z	Survival outcomes of management in metastatic gastric adenocarcinoma patients	Hu H.-M.; Tsai H.-J.; Ku H.-Y.; Lo S.-S.; Shan Y.-S.; Chang H.-C.; Chao Y.; Chen J.-S.; Chen S.-C.; Chiang C.-J.; Li A.F.-Y.; HSIU-PO WANG; Wang T.-E.; Bai L.-Y.; Wu M.-S.; Chen L.-T.; Liu T.-W.; Yang Y.-H.
臺大學術典藏	2022-01-25T07:24:16Z	Survival outcomes of management in metastatic gastric adenocarcinoma patients	Hu H.-M.; Tsai H.-J.; Ku H.-Y.; Lo S.-S.; Shan Y.-S.; Chang H.-C.; Chao Y.; Chen J.-S.; Chen S.-C.; Chiang C.-J.; Li A.F.-Y.; Wang H.-P.; Wang T.-E.; Bai L.-Y.; MING-SHIANG WU; Chen L.-T.; Liu T.-W.; Yang Y.-H.
國立成功大學	2022	Electromagnetically-driven integrated microfluidic platform using reverse transcription loop-mediated isothermal amplification for detection of severe acute respiratory syndrome coronavirus 2	Tsai, Y.-S.;Wang, C.-H.;Tsai, H.-P.;Shan, Y.-S.;Lee, G.-B.
國立成功大學	2022	An integrated microfluidic platform featuring real-time reverse transcription loop-mediated isothermal amplification for detection of COVID-19	Jhou, Y.-R.;Wang, C.-H.;Tsai, H.-P.;Shan, Y.-S.;Lee, G.-B.
國立成功大學	2022	Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study	Chiang, N.-J.;Tan, K.T.;Bai, L.-Y.;Hsiao, C.-F.;Huang, C.-Y.;Hung, Y.-P.;Huang, C.-J.;Chen, S.-C.;Shan, Y.-S.;Chao, Y.;Huang, Y.-H.;Lee, I.-C.;Lee, P.-C.;Su, Y.-Y.;Chen, S.-J.;Yeh, C.-N.;Chen, L.-T.;Chen, M.-H.
國立成功大學	2022	Effect of previous conventional irinotecan treatment in patients with pancreatic cancer being treated with liposomal irinotecan plus 5-fluorouracil and leucovorin	Chiu, T.-J.;Yang, S.-H.;Chiu, S.-C.;Hsueh, S.-W.;Chiang, N.-J.;Li, C.-P.;Bai, L.-Y.;Cheng, F.-M.;Chuang, S.-C.;Shan, Y.-S.;Chan, D.-C.;Chen, L.-T.;Yen, C.-J.;Peng, C.-M.;Su, Y.-Y.;Chen, Y.-Y.;Chen, J.-S.;Chou, W.-C.
國立成功大學	2022	Exendin-4 Attenuates Hepatic Steatosis by Promoting the Autophagy-Lysosomal Pathway	Yu, H.-H.;Wang, H.-C.;Hsieh, M.-C.;Lee, M.-C.;Su, B.-C.;Shan, Y.-S.
國立成功大學	2022	Review of the endocrine organ–like tumor hypothesis of cancer cachexia in pancreatic ductal adenocarcinoma	Yu, Yu Y.-C.;Ahmed, Ahmed A.;Lai, H.-C.;Cheng, W.-C.;Yang, J.-C.;Chang, W.-C.;Chen, L.-M.;Shan, Y.-S.;Ma, W.-L.
國立成功大學	2022	Phosphomimetic Dicer S1016E triggers a switch to glutamine metabolism in gemcitabine-resistant pancreatic cancer	Park, J.M.;Peng, J.-M.;Shen, Y.-S.;Lin, C.-Y.;Hsu, T.-W.;Su, Y.-H.;Chen, H.-A.;Saengboonmee, C.;Chang, J.-S.;Chiu, Chiu C.-F.;Shan, Y.-S.
國立成功大學	2022	Semaphorin 6C Suppresses Proliferation of Pancreatic Cancer Cells via Inhibition of the AKT/GSK3/β-Catenin/Cyclin D1 Pathway	Hung, Y.-H.;Hsu, S.-H.;Hou, Y.-C.;Chu, P.-Y.;Su, Y.-Y.;Shan, Y.-S.;Hung, W.-C.;Chen, L.-T.
國立成功大學	2022	A prospective phase II study of biweekly S-1, leucovorin, and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma – The Taiwan Cooperative Oncology Group T1217 study	Bai, L.-Y.;Li, C.-P.;Shan, Y.-S.;Chuang, S.-C.;Chen, J.-S.;Chiang, N.-J.;Chen, Y.-Y.;Tsou, H.-H.;Chuang, M.-H.;Chiu, Chiu C.-F.;Liu, T.-W.;Chen, L.-T.
國立成功大學	2022	Lithium upregulates growth-associated protein-43 (GAP-43) and postsynaptic density-95 (PSD-95) in cultured neurons exposed to oxygen-glucose deprivation and improves electrophysiological outcomes in rats subjected to transient focal cerebral ischemia foll	Tai, S.-H.;Huang, S.-Y.;Chao, L.-C.;Lin, Y.-W.;Huang, C.-C.;Wu, T.-S.;Shan, Y.-S.;Lee, A.-H.;Lee, E.-J.
臺大學術典藏	2021-09-01T01:54:05Z	Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study	Ch'Ang H.-J.; Lin Y.-L.; Wang H.-P.; Chiu Y.-F.; Chang M.-C.; Hsu C.-H.; Tien Y.-W.; Chen J.-S.; Hsieh R.-K.; Lin P.-W.; Shan Y.-S.; ANN-LII CHENG; Chang J.-Y.; Whang-Peng J.; Hwang T.-L.; Chen L.-T.
臺大學術典藏	2021-08-12T04:01:23Z	A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma�VTCOG T1211 study	Chiang N.-J.; Tsai K.K.; Hsiao C.-F.; YANG SHIH-HUNG; Hsiao H.-H.; Shen W.-C.; Hsu C.; Lin Y.-L.; Chen J.-S.; Shan Y.-S.; Chen L.-T.
臺大學術典藏	2021-08-12T04:01:22Z	Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study	Chiang N.-J.; Chen M.-H.; YANG SHIH-HUNG; Hsu C.; Yen C.-J.; Tsou H.-H.; Su Y.-Y.; Chen J.-S.; Shan Y.-S.; Chen L.-T.
臺大學術典藏	2021-08-10T03:53:01Z	A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma�VTCOG T1211 study	Chiang N.-J.; Tsai K.K.; Hsiao C.-F.; SHIH-HUNG YANG; Hsiao H.-H.; Shen W.-C.; Hsu C.; Lin Y.-L.; Chen J.-S.; Shan Y.-S.; Chen L.-T.
臺大學術典藏	2021-08-10T03:53:00Z	Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study	Chiang N.-J.; Chen M.-H.; SHIH-HUNG YANG; Hsu C.; Yen C.-J.; Tsou H.-H.; Su Y.-Y.; Chen J.-S.; Shan Y.-S.; Chen L.-T.
臺大學術典藏	2021-03-05T06:07:25Z	Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study	Ch'Ang H.-J.; Lin Y.-L.; Wang H.-P.; Chiu Y.-F.; MING-CHU CHANG; Hsu C.-H.; Tien Y.-W.; Chen J.-S.; Hsieh R.-K.; Lin P.-W.; Shan Y.-S.; Cheng A.-L.; Chang J.-Y.; Whang-Peng J.; Hwang T.-L.; Chen L.-T.
臺大學術典藏	2021-02-23T08:26:14Z	The Epidemiology of Gastric Cancers in the Era of Helicobacter pylori Eradication: A nationwide cancer registry-based study in Taiwan	Chang J.S.;Sung-Hsin Kuo;Chu P.-Y.;Shan Y.-S.;Tsai C.-R.;Tsai H.-J.;Chen L.-T.; Chang J.S.; SUNG-HSIN KUO; Chu P.-Y.; Shan Y.-S.; Tsai C.-R.; Tsai H.-J.; Chen L.-T.
臺大學術典藏	2021-02-18T02:09:12Z	A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma�VTCOG T1211 study	Chiang N.-J.;Tsai K.K.;Hsiao C.-F.;Yang S.-H.;Hsiao H.-H.;Shen W.-C.;Chiun Hsu;Lin Y.-L.;Chen J.-S.;Shan Y.-S.;Chen L.-T.; Chiang N.-J.; Tsai K.K.; Hsiao C.-F.; Yang S.-H.; Hsiao H.-H.; Shen W.-C.; Chiun Hsu; Lin Y.-L.; Chen J.-S.; Shan Y.-S.; Chen L.-T.
臺大學術典藏	2021-02-18T01:45:22Z	An Open-Label, Single-Arm, Two-Stage, Multicenter, Phase II Study to Evaluate the Efficacy of TLC388 and Genomic Analysis for Poorly Differentiated Neuroendocrine Carcinomas	Chen M.-H.;Chou W.-C.;Hsiao C.-F.;Jiang S.S.;Tsai H.-J.;Liu Y.-C.;Chiun Hsu;Shan Y.-S.;Hung Y.-P.;Hsich C.-H.;Chiu C.-H.;Liu T.-C.;Cho S.-F.;Liu T.-W.;Chao Y.; Chen M.-H.; Chou W.-C.; Hsiao C.-F.; Jiang S.S.; Tsai H.-J.; Liu Y.-C.; Chiun Hsu; Shan Y.-S.; Hung Y.-P.; Hsich C.-H.; Chiu C.-H.; Liu T.-C.; Cho S.-F.; Liu T.-W.; Chao Y.
臺大學術典藏	2021-02-18T01:45:20Z	Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study	Chiang N.-J.;Chen M.-H.;Yang S.-H.;Chiun Hsu;Yen C.-J.;Tsou H.-H.;Su Y.-Y.;Chen J.-S.;Shan Y.-S.;Chen L.-T.; Chiang N.-J.; Chen M.-H.; Yang S.-H.; Chiun Hsu; Yen C.-J.; Tsou H.-H.; Su Y.-Y.; Chen J.-S.; Shan Y.-S.; Chen L.-T.
臺大學術典藏	2021-01-28T01:06:35Z	Management of gastric cancer in Asia: Resource-stratified guidelines	Shen L.;Shan Y.-S.;Hu H.-M.;Price T.J.;Sirohi B.;Kun-Huei Yeh;Yang Y.-H.;Sano T.;Yang H.-K.;Zhang X.;Park S.R.;Fujii M.;Kang Y.-K.;Chen L.-T.; Shen L.; Shan Y.-S.; Hu H.-M.; Price T.J.; Sirohi B.; KUN-HUEI YEH; Yang Y.-H.; Sano T.; Yang H.-K.; Zhang X.; Park S.R.; Fujii M.; Kang Y.-K.; Chen L.-T.
臺大學術典藏	2021-01-15T03:47:00Z	Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study	Ch'Ang H.-J.; Lin Y.-L.; HSIU-PO WANG; Chiu Y.-F.; Chang M.-C.; Hsu C.-H.; Tien Y.-W.; Chen J.-S.; Hsieh R.-K.; Lin P.-W.; Shan Y.-S.; Cheng A.-L.; Chang J.-Y.; Whang-Peng J.; Hwang T.-L.; Chen L.-T.
國立成功大學	2021	Comparing the clinicopathological characteristics of combined hepatocellular–cholangiocarcinoma with those of other primary liver cancers by use of the updated World Health Organization classification	Yen, C.-C.;Yen, C.-J.;Shan, Y.-S.;Lin, Y.-J.;Liu, I.-T.;Huang, Huang H.-Y.;Yeh, M.M.;Chan, S.-H.;Tsai, H.-W.
國立成功大學	2021	No association between alcohol consumption and pancreatic cancer even among individuals genetically susceptible to the carcinogenicity of alcohol	Shan, Y.-S.;Chen, L.-T.;Wu, C.-H.;Chang, Y.-F.;Lee, C.-T.;Chiang, N.-J.;Chao, Y.-J.;Yen, C.-J.;Tsai, H.-J.;Huang, Huang H.-E.;Tsai, C.-R.;Weng, Y.-L.;Yang, H.-C.;Liu, H.-C.;Chang, J.S.
國立成功大學	2021	High expression of kr�ppel-like factor 10 or Smad4 predicts clinical benefit of adjuvant chemoradiotherapy in curatively resected pancreatic adenocarcinoma: From a randomized phase III trial	Pen, S.-L.;Shan, Y.-S.;Hsiao, C.-F.;Liu, T.-W.;Chen, J.-S.;Ho, C.-L.;Chou, W.-C.;Hsieh, R.-K.;Chen, L.-T.;Ch'ang, H.-J.
國立成功大學	2021	Survival outcomes of management in metastatic gastric adenocarcinoma patients	Hu, Hu H.-M.;Tsai, H.-J.;Ku, H.-Y.;Lo, S.-S.;Shan, Y.-S.;Chang, H.-C.;Chao, Y.;Chen, J.-S.;Chen, S.-C.;Chiang, Chiang C.-J.;Li, A.F.-Y.;Wang, H.-P.;Wang, T.-E.;Bai, L.-Y.;Wu, M.-S.;Chen, L.-T.;Liu, T.-W.;Yang, Yang Y.-H.
國立成功大學	2021	Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients’ experience within a population-based study	Chiu, T.-J.;Su, Y.-Y.;Yang, S.-H.;Li, C.-P.;Bai, L.-Y.;Chiang, N.-J.;Chuang, S.-C.;Shan, Y.-S.;Chan, D.-C.;Chen, L.-T.;Yen, C.-J.;Peng, C.-M.;Chen, Y.-Y.;Chen, J.-S.;Chou, W.-C.
國立成功大學	2021	Upregulation of peroxisome proliferator-activated receptor-α and the lipid metabolism pathway promotes carcinogenesis of ampullary cancer	Wang, C.-Y.;Chao, Y.-J.;Chen, Y.-L.;Wang, T.-W.;Phan, N.N.;Hsu, Hsu H.-P.;Shan, Y.-S.;Lai, M.-D.
國立成功大學	2021	A multi-mode Wnt- and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancer	Hsu, C.-C.;Liao, W.-Y.;Chang, K.-Y.;Chan, T.-S.;Huang, P.-J.;Chiang, Chiang C.-T.;Shan, Y.-S.;Cheng, L.-H.;Liao, T.-Y.;Tsai, K.K.
國立成功大學	2021	c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation	Chang, T.-M.;Chu, P.-Y.;Hung, W.-C.;Shan, Y.-S.;Lin, H.-Y.;Huang, K.-W.;Chang, J.S.;Chen, L.-T.;Tsai, H.-J.
國立成功大學	2021	The Prognostic and Predictive Role of Chromogranin A in Gastroenteropancreatic Neuroendocrine Tumors – A Single-Center Experience	Tsai, H.-J.;Hsiao, C.-F.;Chang, J.S.;Chen, L.-T.;Chao, Y.-J.;Yen, C.-J.;Shan, Y.-S.
國立成功大學	2021	Development of possible next line of systemic therapies for gemcitabine-resistant biliary tract cancers: A perspective from clinical trials	Chiang, N.-J.;Chen, L.-T.;Shan, Y.-S.;Yeh, C.-N.;Chen, M.-H.
臺大學術典藏	2020-04-28T07:25:25Z	Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study	Ch'Ang H.-J.; Lin Y.-L.; Wang H.-P.; Chiu Y.-F.; Chang M.-C.; CHIH-HUNG HSU; Tien Y.-W.; Chen J.-S.; Hsieh R.-K.; Lin P.-W.; Shan Y.-S.; Cheng A.-L.; Chang J.-Y.; Whang-Peng J.; Hwang T.-L.; Chen L.-T.; Ch'Ang H.-J. ;Lin Y.-L. ;Wang H.-P. ;Chiu Y.-F. ;Chang M.-C. ;Chih-Hung Hsu ;Tien Y.-W. ;Chen J.-S. ;Hsieh R.-K. ;Lin P.-W. ;Shan Y.-S. ;Cheng A.-L. ;Chang J.-Y. ;Whang-Peng J. ;Hwang T.-L. ;Chen L.-T.
臺大學術典藏	2020-04-10T12:51:03Z	Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer	Chen L.-T.; Huang S.-F.; Chen J.-S.; Tsou H.-H.; Shen Y.-Y.; Chao Y.; Chen M.-H.; Yeh T.-S.; Shan Y.-S.; Chiun Hsu; Chiang N.-J.; Chiang N.-J.;Chiun Hsu;Chen J.-S.;Tsou H.-H.;Shen Y.-Y.;Chao Y.;Chen M.-H.;Yeh T.-S.;Shan Y.-S.;Huang S.-F.;Chen L.-T.
臺大學術典藏	2020-03-07T06:48:18Z	Krüppel-like factor 10 expression as a prognostic indicator for pancreatic adenocarcinoma	Ch'Ang H.-J.; Yu W.C.Y.; Tsai K.K.C.; Lin C.-Y.; Hsu C.-F.; Shan Y.-S.; Chu P.-Y.; Peng S.-L.; TSUI-LIEN MAO; Chang V.H.S.
臺大學術典藏	2020-03-05T12:32:51Z	Kr?ppel-like factor 10 expression as a prognostic indicator for pancreatic adenocarcinoma	Chang V.H.S.; Chu P.-Y.; Peng S.-L.; TSUI-LIEN MAO; Shan Y.-S.; Hsu C.-F.; Lin C.-Y.; Tsai K.K.C.; Yu W.C.Y.; Ch'Ang H.-J.
臺大學術典藏	2020-02-20T06:53:13Z	Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study	Chang J.-Y.; Whang-Peng J.; Hwang T.-L.; Chen L.-T.; Shan Y.-S.; Cheng A.-L.; Lin P.-W.; Chen J.-S.; Hsieh R.-K.; YU-WEN TIEN; Ch'Ang H.-J.;Lin Y.-L.;Wang H.-P.;Chiu Y.-F.;Chang M.-C.;Hsu C.-H.;Yu-Wen Tien;Chen J.-S.;Hsieh R.-K.;Lin P.-W.;Shan Y.-S.;Cheng A.-L.;Chang J.-Y.;Whang-Peng J.;Hwang T.-L.;Chen L.-T.; Ch'Ang H.-J.; Lin Y.-L.; Wang H.-P.; Chiu Y.-F.; Chang M.-C.; Hsu C.-H.
臺大學術典藏	2020	Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study	Su Y.-Y.; Chen J.-S.; Shan Y.-S.; Chen L.-T.; Tsou H.-H.; CHIUN HSU; Yen C.-J.; Yang S.-H.; Chen M.-H.; Chiang N.-J.
臺大學術典藏	2020	A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma�VTCOG T1211 study	Shen W.-C.; CHIUN HSU; Lin Y.-L.; Chen J.-S.; Shan Y.-S.; Chen L.-T.; Hsiao H.-H.; Yang S.-H.; Tsai K.K.; Hsiao C.-F.; Chiang N.-J.
國立成功大學	2020	Validation of genome-wide association study-identified single nucleotide polymorphisms in a case-control study of pancreatic cancer from Taiwan	Shan, Y.-S.;Chen, L.-T.;Wu, J.-S.;Chang, Y.-F.;Lee, C.-T.;Wu, C.-H.;Chiang, N.-J.;Huang, Huang H.-E.;Yen, C.-J.;Chao, Y.-J.;Tsai, H.-J.;Chen, Chen C.-Y.;Kang, J.-W.;Kuo, C.-F.;Tsai, C.-R.;Weng, Y.-L.;Yang, H.-C.;Liu, H.-C.;Chang, J.S.
國立成功大學	2020	OSU-A9 induced-reactive oxygen species cause cytotoxicity in duodenal and gastric cancer cells by decreasing phosphorylated nuclear pyruvate kinase M2 protein levels	Chiu, Chiu C.-F.;Weng, J.-R.;Lee, S.-L.;Wu, C.-Y.;Chu, P.-C.;Shan, Y.-S.;Yang, H.-R.;Bai, L.-Y.
國立成功大學	2020	Risk factors for pancreatic fistula grade C after pancreatoduodenectomy: A large prospective, multicenter Japan-Taiwan collaboration study	Hirono, S.;Shimokawa, T.;Nagakawa, Y.;Shyr, Y.-M.;Kawai, M.;Matsumoto, I.;Satoi, Satoi S.;Yoshitomi, H.;Okabayashi, T.;Motoi, F.;Amano, R.;Murakami, Y.;Hirano, S.;Kawamoto, Kawamoto K.;Nakamori, S.;Shan, Y.-S.;Kobayashi, S.;Nitta, H.;Matsukawa, H.;Uchiyama, K.;Hsu, C.-P.;Kitami, C.;Yamamoto, M.;Hwang, T.-L.;Yamaue, H.
國立成功大學	2020	Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI-1 study	Bang, Y.-J.;Li, C.-P.;Lee, K.-H.;Chiu, Chiu C.-F.;Park, J.O.;Shan, Y.-S.;Kim, J.S.;Chen, J.-S.;Shim, H.-J.;Rau, K.-M.;Choi, H.J.;Oh, D.-Y.;Belanger, Belanger B.;Chen, L.-T.
國立成功大學	2020	Cancer-derived transforming growth factor-β modulates tumor-associated macrophages in ampullary cancer	Cheng, L.-C.;Chao, Y.-J.;Wang, C.-Y.;Phan, N.N.;Chen, Y.-L.;Wang, T.-W.;Hsu, Hsu H.-P.;Lin, Y.-J.;Shan, Y.-S.;Lai, M.-D.
國立成功大學	2020	An Open-Label, Single-Arm, Two-Stage, Multicenter, Phase II Study to Evaluate the Efficacy of TLC388 and Genomic Analysis for Poorly Differentiated Neuroendocrine Carcinomas	Chen, M.-H.;Chou, W.-C.;Hsiao, C.-F.;Jiang, S.S.;Tsai, H.-J.;Liu, Y.-C.;Hsu, C.;Shan, Y.-S.;Hung, Y.-P.;Hsich, C.-H.;Chiu, Chiu C.-H.;Liu, T.-C.;Cho, S.-F.;Liu, T.-W.;Chao, Y.
國立成功大學	2020	A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma–TCOG T1211 study	Chiang, N.-J.;Tsai, K.K.;Hsiao, C.-F.;Yang, S.-H.;Hsiao, Hsiao H.-H.;Shen, W.-C.;Hsu, C.;Lin, Y.-L.;Chen, J.-S.;Shan, Y.-S.;Chen, L.-T.
國立成功大學	2020	Loss of EGR-1 uncouples compensatory responses of pancreatic β cells	Leu, S.-Y.;Kuo, L.-H.;Weng, Weng W.-T.;Lien, I.-C.;Yang, C.-C.;Hsieh, T.-T.;Cheng, Y.-N.;Chien, P.-H.;Ho, L.-C.;Chen, S.-H.;Shan, Y.-S.;Chen, Y.-W.;Tsai, P.-J.;Sung, J.-M.;Tsai, Y.-S.

顯示項目 16-65 / 95 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 53252798 線上人數 : 662 教育部委託研究計畫計畫執行:國立臺灣大學圖書館